371 related articles for article (PubMed ID: 21286703)
1. Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.
Lu H; Wu Z; Xu W; Yang J; Chen Y; Li L
Microb Ecol; 2011 Apr; 61(3):693-703. PubMed ID: 21286703
[TBL] [Abstract][Full Text] [Related]
2. Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease.
Xu M; Wang B; Fu Y; Chen Y; Yang F; Lu H; Chen Y; Xu J; Li L
Microb Ecol; 2012 Feb; 63(2):304-13. PubMed ID: 21814872
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis of fecal microbiota in Crohn's disease patients as revealed by a custom phylogenetic microarray.
Kang S; Denman SE; Morrison M; Yu Z; Dore J; Leclerc M; McSweeney CS
Inflamm Bowel Dis; 2010 Dec; 16(12):2034-42. PubMed ID: 20848492
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant.
Wu ZW; Lu HF; Wu J; Zuo J; Chen P; Sheng JF; Zheng SS; Li LJ
Microb Ecol; 2012 May; 63(4):929-37. PubMed ID: 21965156
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Clinical Significance of Intestinal Microbiota in Patients with Chronic Hepatitis B Cirrhosis and Type 2 Diabetes Mellitus.
Sun X; Chi X; Zhao Y; Liu S; Xing H
J Diabetes Res; 2022; 2022():1826181. PubMed ID: 35601017
[TBL] [Abstract][Full Text] [Related]
8. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
9. Effects of intestinal colonization by Clostridium difficile and Staphylococcus aureus on microbiota diversity in healthy individuals in China.
Dong D; Ni Q; Wang C; Zhang L; Li Z; Jiang C; EnqiangMao ; Peng Y
BMC Infect Dis; 2018 May; 18(1):207. PubMed ID: 29724187
[TBL] [Abstract][Full Text] [Related]
10. Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach.
Wei X; Yan X; Zou D; Yang Z; Wang X; Liu W; Wang S; Li X; Han J; Huang L; Yuan J
BMC Gastroenterol; 2013 Dec; 13():175. PubMed ID: 24369878
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of fecal microbiota and intestinal microbial metabolic activity in captive polar bears.
Schwab C; Gänzle M
Can J Microbiol; 2011 Mar; 57(3):177-85. PubMed ID: 21358758
[TBL] [Abstract][Full Text] [Related]
12. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota.
Bartosch S; Fite A; Macfarlane GT; McMurdo ME
Appl Environ Microbiol; 2004 Jun; 70(6):3575-81. PubMed ID: 15184159
[TBL] [Abstract][Full Text] [Related]
13. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.
Zwielehner J; Lassl C; Hippe B; Pointner A; Switzeny OJ; Remely M; Kitzweger E; Ruckser R; Haslberger AG
PLoS One; 2011; 6(12):e28654. PubMed ID: 22194876
[TBL] [Abstract][Full Text] [Related]
14. Changes of gut bacteria and immune parameters in liver transplant recipients.
Wu ZW; Ling ZX; Lu HF; Zuo J; Sheng JF; Zheng SS; Li LJ
Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):40-50. PubMed ID: 22251469
[TBL] [Abstract][Full Text] [Related]
15. Chicken intestine microbiota following the administration of lupulone, a hop-based antimicrobial.
Tillman GE; Haas GJ; Wise MG; Oakley B; Smith MA; Siragusa GR
FEMS Microbiol Ecol; 2011 Aug; 77(2):395-403. PubMed ID: 21517917
[TBL] [Abstract][Full Text] [Related]
16. Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project.
Ling Z; Liu X; Cheng Y; Jiang X; Jiang H; Wang Y; Li L
Sci Rep; 2015 Nov; 5():17098. PubMed ID: 26606973
[TBL] [Abstract][Full Text] [Related]
17. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers.
Vanhoutte T; Huys G; Brandt E; Swings J
FEMS Microbiol Ecol; 2004 Jun; 48(3):437-46. PubMed ID: 19712312
[TBL] [Abstract][Full Text] [Related]
18. Functional gene arrays-based analysis of fecal microbiomes in patients with liver cirrhosis.
Chen Y; Qin N; Guo J; Qian G; Fang D; Shi D; Xu M; Yang F; He Z; Van Nostrand JD; Yuan T; Deng Y; Zhou J; Li L
BMC Genomics; 2014 Sep; 15(1):753. PubMed ID: 25179593
[TBL] [Abstract][Full Text] [Related]
19. Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population.
Pérez-Monter C; Escalona-Nandez I; Estanes-Hernández A; Noriega-López LG; Torre-Delgadillo A
Rev Gastroenterol Mex (Engl Ed); 2019; 84(1):26-35. PubMed ID: 29903529
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacteria in fecal samples.
Wang RF; Beggs ML; Robertson LH; Cerniglia CE
FEMS Microbiol Lett; 2002 Aug; 213(2):175-82. PubMed ID: 12167534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
